Literature DB >> 26042518

Nonalcoholic Fatty Liver: The Association with Metabolic Abnormalities, Body Mass Index and Central Obesity--A Population-Based Study.

Mohammad Reza Ostovaneh1,2, Farhad Zamani3, Alireza Ansari-Moghaddam4, Maryam Sharafkhah2, Fatemeh Sima Saeedian3, Zohreh Rohani4, Mohammadreza Khoonsari4, Gilda Barzin2, Gholamreza Hemmasi3, Hossein Ajdarkosh3, Aezam Katoonizadeh2, Mansoureh Maadi3, Reza Malekzadeh5, Hossein Poustchi2.   

Abstract

BACKGROUND: To assess the prevalence of nonalcoholic fatty liver (NAFL) in Iran and to evaluate correlates of NAFL in categories of body mass index (BMI).
METHODS: Using a cluster random sampling approach, 7723 subjects over 18 years of age underwent abdominal ultrasonography, laboratory evaluations, blood pressure, and anthropometric measurements and were interviewed to obtain baseline characteristics. Prevalence of NAFL according to BMI and waist to hip ratio and its association with metabolic abnormalities in categories of BMI were assessed in multivariate analysis.
RESULTS: The overall prevalence of NAFL was 35.2% [95% confidence interval (CI) 34.1-36.3]. A significant number of subjects with BMI < 30 had NAFL [22.1% (CI 21.0-23.2)]. Waist to hip ratio for 38.2% (CI 35.6-40.8) of the subjects with NAFL, and BMI < 30 was higher than normal values. The odds ratio for association of NAFL and dyslipidemias were higher in subjects with BMI < 30 versus those with BMI ≥ 30: (1) hypertriglyceridemia: 2.21 vs. 1.57, P = 0.006; (2) lower high-density lipoprotein: 1.29 versus 0.98, P = 0.046. Higher low-density lipoprotein also revealed greater association with NAFL in subjects with BMI < 25 than those with BMI ≥ 25 (odds ratio 1.84 vs. 1.1, P = 0.015).
CONCLUSIONS: NAFL shows stronger association with central obesity compared to high BMI. NAFL has stronger association with dyslipidemias in subjects with low compared with high BMI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26042518     DOI: 10.1089/met.2014.0131

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  5 in total

1.  What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?

Authors:  Mariana V Machado; Sara Policarpo; J Coutinho; Sofia Carvalhana; Jorge Leitão; Armando Carvalho; Ana P Silva; Francisco Velasco; Isabel Medeiros; Ana Catarina Alves; Mafalda Bourbon; Helena Cortez-Pinto
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

Review 2.  Prevalence of Non-alcoholic Fatty Liver Disease and Its Related Factors in Iran.

Authors:  I Moghaddasifar; K B Lankarani; M Moosazadeh; M Afshari; A Ghaemi; M Aliramezany; R Afsar Gharebagh; M Malary
Journal:  Int J Organ Transplant Med       Date:  2016-08-01

3.  HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric Parameters.

Authors:  Muhammad Masroor; Zeba Haque
Journal:  J Clin Transl Hepatol       Date:  2021-01-02

Review 4.  Circulating non-coding RNAs as potential diagnostic biomarkers in liver diseases.

Authors:  Fedra Mokhtari; Seyed Reza Mohebbi; Afsaneh Sharifian; Marzieh Ramandi; Mohammad Reza Razzaghi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2021

5.  Association between central obesity and incident diabetes mellitus among Japanese: a retrospective cohort study using propensity score matching.

Authors:  Changchun Cao; Haofei Hu; Xiaodan Zheng; Xiaohua Zhang; Yulong Wang; Yongcheng He
Journal:  Sci Rep       Date:  2022-08-04       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.